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Abstract
Background: Diosgenin, a naturally occurring steroid saponin found abundantly in C. speciosus, is a well-known
precursor of various synthetic steroidal drugs that are extensively used in the pharmaceutical industry.
Methods: The present study was conducted to evaluate the in vitro anticancer and apoptotic effects on cell
proliferation of diosgenin isolated from C. speciosus (Koen.) Sm.
Results: The results indicated that the treatment of HepG2 cells with the sample resulted in a cytotoxic effect as
concluded from the IC50 value 32.62 μg/ml, while the treatment of HepG2 cells with paclitaxel, a known anti-cancer
drug, resulted in an IC50 value of 0.48 μg/ml. The treatment of MCF-7 cells with the tested sample resulted in high
inhibition in the cell viability, and resulted in an IC50 value of 11.03 μg/ml, while the treatment of MCF-7 cells with
paclitaxel resulted in an IC50 value of 0.61 μg/ml. The levels of DR4 and caspase-3 were significantly increased
(P < 0.01) in MCF-7 cells treated with the tested sample compared to untreated cells and possessed a similar activity
of paclitaxel in DR4 induction but lower induction in caspase-3. On the other hand the treatment of macrophages
or lymphocytes with diosgenin (250 μg/ml) resulted in an induction in the cell proliferation up to 3.2-fold and
2.1-fold of control, respectively.
Conclusions: The results presented here may suggest that diosgenin isolated from C. speciosus possess anticancer
and apoptotic effects on cell proliferation, and therefore, can be used as pharmaceuticals drugs.
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Background
Costus speciosus is used as food and medicine by the
Kannikars, the primitive hill tribes of South India [1].
Recently it is used in drug industry as a natural source
of diosgenin which is a steroidal sapogenin used for syn-
thesis of sex hormones, cortisone and oral contracep-
tives [2]. Diosgenin content up to 3.37 % has been
reported in rhizome of C. speciosus [3]. Diosgenin
(Fig. 1), is a precursor of sex hormones (progesterone),
corticosteroids (corticosone) and contraceptives [4]. Di-
osgenin induces apoptosis in cancerous cells by cycloox-
ygenase up -regulation and in HeLa cells by caspase
pathway [5]. Dioscin, a derivative compound from Dios-
genin, has been reported to induce apoptosis in HeLa
cells through caspase −9 and caspase-3 pathway [6]. It
causes an inhibition of growth of fibroblast –like syno-
viocytes in human rheumatoid arthritis with apoptosis
induction associated with cylooxygenase-2 up-regulation
[7]. Diosgenin has both antioxidant property and anti-
cholesterolomic activity. It has been reported to have
various effects such as hypocholesterolemic action in rat
[8], antioxidant activity in HIV patients with dementia
and apoptosis through cyclooxygenase activity in osteo-
sarcoma cells [9]. Cholesterol-lowering activity of sapo-
nins, which was demonstrated in animal [10], and
human trials were attributed to inhibition of the absorp-
tion of cholesterol from the small intestine, or the re -ab-
sorption of bile acids [11]. So, in the present study, we
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evaluated the anticancer and apoptotic effects on cell Pro-
liferation activities of diosgenin isolated from C. speciosus.
Methods
Raw material
C. speciosus was procured from a fixed vendor in the
local market of Al Jouf, KSA. Specimens were identified
at the Aljouf University (Aljouf, Saudi Arabia) and vou-
cher specimen (No. 13) was deposited at the Herbarium
of the Department in the cited university. All cell maintain-
ing materials was obtained from Cambrex, BioScience
(Copenhagen, Denmark), while all other fine chemicals
were from Sigma-Aldrich (CT, USA).
Hydrolysis and HPTLC analysis
Dried tuber powder (5 g) was treated with slightly modi-
fied method described by Drapeau et al. [12]. Samples
were hydrolyzed in 150 ml of refluxing 20 % H2SO4 in
70 % isopropanol for 8 h. The extract was filtered and
extracted with hexane (50 ml × 3). The three hexane ex-
tracts were combined and rinsed thrice times with 5 %
alkali and then rinsed thrice with distilled water. The ex-
tract was then passed through a column of Na2SO4 to
eliminate any remaining water. The samples were con-
centrated to dryness by evaporating the solvent at 40 °C
in a Rotary evaporator. The dried crude extract was sol-
ubilized in 0.5 ml of chloroform prior to the quantitative
determination of diosgenin by thin layer chromatog-
raphy as reported by Kshirsagar et al. [13].
Cell culture for cancer cell lines
Hepatocellular carcinoma Hep G2 Cells, breast adenocar-
cinoma MCF-7 cells and colon carcinoma HCT-116 cells
were purchased from ATCC, VA, USA. HepG2 and MCF-
7 cells were cultured in RPMI medium, while HCT-116
cells were cultured in McCoy’s medium. Both were sup-
plemented with 10 % fetal bovine serum, 2 μmol/ml L-glu-
tamine, 250 ng/ml fungizone, 100 units/ml penicillin G
sodium, and 100 units/ml streptomycin sulphate at 37 °C
in a humidified 5 % CO2 incubator. The cultures were
passaged every four days by trypsinization using 1 ml
trypsin/EDTA solution for 5 min at 37 °C. Cells were used
when confluence had reached 75 %. Trypsin/EDTA so-
lution consists of 0.25 mM trypsin and 1 mM EDTA
dissolved in phosphate buffer [14].
Cell culture for immune cells
Lymphoblastic leukemia 1301 cells and raw murine
macrophage (RAW 264.7) cell lines were purchased
from ATCC, VA, USA. RAW 264.7 cells were grown in
RPMI-1640. Media were supplemented with 10 % fetal
bovine serum (FBS), 2 mM L-glutamine, containing 100
units/ml penicillin G sodium, 100 units/ml streptomycin
sulphate, and 250 ng/ml amphotericin B. Cells were
maintained at sub-confluency at 37 °C in humidified air
containing 5 % CO2. For sub-culturing, monolayer cells
were harvested by scraping. Cells were used when con-
fluence had reached 75 % [14].
Preparation of cell lysates for ELISA
After cells treatment as the experimental design, col-
lected cells were washed and centrifuged for 10 min at
1000 × g. Cell pellets were lysed in 0.5 ml of ice-cold
lysis buffer. This buffer consists of 50 mM Tris HCl,
150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 20 mM
NaF, 100 mM Na3VO4, 0.5 % NP40, 1 % Triton X-100,
1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aproti-
nin, and 10 mg/ml leupeptin (pH 7.4). Cell lysates were
passed through a 21-gauge needle to break up cell ag-
gregates, and then centrifuged at 14,000 × g for 15 min
at 4 °C [14].
Anticancer assay
Cytotoxicity of tested sample against different cancer cell
lines was measured using the MTT Cell Viability Assay.
MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazo-
lium bromide) assay is based on the ability of active
mitochondrial dehydrogenase enzyme of living cells to
cleave the tetrazolium rings of the yellow MTT (5 mg/
ml of MTT in 0.9 % NaCl) and form blue insoluble for-
mazan crystals. Solubilization of the crystals by acidified
isopropanol (0.04 N HCl in absolute isopropanol) was
carried out. The extent of the reduction of MTT was
quantified by measuring the absorbance at 570 nm [14].
The number of viable cells is directly proportional to the
level of soluble formazan dark blue color.
Cells (0.5×105 cells/well) in serum-free media were
placed in a flat bottom 96-well microplate, and treated
with 20 μl of different concentrations of the tested sam-
ple for 20 h at 37 °C, in a humidified 5 % CO2 atmos-
phere. After incubation for 24 h, cell was submitted to
MTT assay. Triplicate repeats were performed for each
concentration and the average was calculated. Data were
expressed as the percentage of relative viability com-
pared with the untreated cells compared with the vehicle
Fig. 1 Chemical structure of diosgenin
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control, with cytotoxicity indicated by <100 % relative
viability. The percentage of relative viability was calcu-
lated using the following equation:
Absorbance of treated cells=Absorbance of control cells½ X 100
The half maximal inhibitory concentration of cell via-
bility (IC50) was calculated by from the linear equation
of sample concentration and cell viability %.
Cell death mode and mediators
Cell cycle analysis
MCF-7 cells (5×105) were collected after different treat-
ments, and then washed two times with PBS, resus-
pended in 300 μl of PBS, and fixed with 4 ml of ice-cold
70 % ethanol. The cells were centrifuged to remove etha-
nol and washed once in PBS. The cell pellets were then
resuspended in 1 ml of a solution of 0.1 % Triton X-100
in PBS, 0.2 mg/ml RNase A, and 10 μg/ml propidium
iodide (PI) and incubated for 30 min at room
temperature. The stained cells were analyzed by flow cy-
tometry [14].
Fluorescence analysis of apoptosis and necrosis in living
cells
The mode of cell death was determined by investigating
apoptosis and necrosis ratios using double stain with
acridine orange/ethidium bromide according to the
method of Ribble et al., [15]. Acridine orange/ethidium
bromide (AO/EB, 100 μg/ml PBS) staining is used to
visualize nuclear changes and apoptotic body formation
that are characteristic of apoptosis. AO is a nucleic acid
selective fluorescent cationic membrane-permeable dye
that will stain all cells and makes the nuclei appears
green. EB is a dye that is only taken up by cells when
cytoplasmic membrane integrity is lost, to intercalate
DNA staining the nucleus red. AO permeates all cells
staining the nuclei green, where EB is only taken up by
cells losing their cytoplasmic membrane integrity stain-
ing the nucleus red. Thus live cells have a normal green
nucleus; early apoptotic cells have bright green to yel-
low nucleus with condensed or fragmented chromatin;
late apoptotic cells display fragmented orange chroma-
tin and cells have died from direct necrosis have a
structurally dark orange to red nucleus. Cells were cul-
tured in six well plates at a density of 5 × 105 cells/well.
Triplicate wells were treated with tested sample and in-
cubated for 48 h at 37 °C in a humidified 5 % CO2 at-
mosphere. Finally cells were removed by trypsinization
and resuspended in 50 μl PBS and 2 μl of a solution
containing 100 μg/ml AO and 100 μg/ml EB in PBS
was added. Stained cell suspension (10 μl) was placed
on a clean microscope slide and covered with a cover-
slip. Cells were visualized and counted by fluorescence
microscopy. For each sample, at least 500 cells were
counted, and the percentage of apoptotic or necrotic
cells was determined as:
% of apoptotic or necrotic ¼ ðthe total number of
apoptotic or necrotic cells=total number of
cells countedÞ x 100:
Estimation of caspase-3 and death receptor-4
The levels of Caspase-3 and death receptor (DR-4) were
measured in cell lysate by the quantitative indirect im-
munoassay ELISA technique, according to the method
of Wang et al. [16]. The following reagents were pre-
pared: Washing buffer (PBS/0.05 % polyoxyethylene-20;
Tween-20); blocking buffer (PBS/0.05 % Tween-20/5 %
FBS); diluents buffer (PBS/Tween-20/1 % FBS); and sub-
strate buffer (equal volumes of 3,3',5,5'-tetramethyl ben-
zidine [TMB; o.4 g/]) and H2O2 [0.02 % in citric acid
buffer; KPL, Kirkegaard and Perry Lab. Gaithersburg,
MD, USA]). Briefly, 96-wells bottom polystyrene micro-
plates were coated with cell lysates (50 μl/well) and incu-
bated for 1 h at 37 °C and then washed by washing
buffer before incubated with blocking buffer for 90 min
at 37 °C. The wells were washed and then antibodies
(1 mg/ml Rabbit polyclonal to DR-4 or caspase-3, Abcam
Inc., Cambridge, MA, USA) were added. After the incuba-
tion for 1 h at 37 °C, polyclonal Goat anti-rabbit peroxidase
conjugate (1:2000, Jackson Immunsearch Lab, USA) was
added to wells. After 1 h, wells were washed and the sub-
strate buffer was applied and the color development was
stopped by adding 1 M HCl. The intensity of the developed
yellow color was measured at 450 nm using microplate
reader (FLUOstar OPTIMA, BMG LABTECH GmbH,
Offenburg, Germany). The level of DR-4 was expressed as
optical densities values and compared with the activity of
paclitaxel.
Proliferation index of lymphocytes and macrophages
The effect of the tested sample proliferation index of
lymphocytes and macrophages was investigated using
the MTT Assay in lymphoblastic leukemia 1301 cells
and raw murine macrophage (RAW 264.7). Cells
(0.5×105 cells/well) in serum-free media were placed
in a flat bottom 96-well microplate, and treated with
20 μl of different concentrations of the tested sample. After
incubation for 72 h, cells were submitted to MTT assay.
The results were compared with Echinacea purpurea root
extract as a known standard immunostimulant.
Statistical analysis
Data were statistically analyzed using IBM computer
supplied with Statistical Package for Social Scientists
(SPSS) 10.00 for windows (SPSS Inc., Chicago, IL., USA).
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The student's unpaired t-test as was used to detect the
statistical significance. P value was considered insignifi-
cant if more than 0.05.
Results and discussion
Currently chemotherapy is regarded as one of the most
efficient cancer treatment approach. Although chemo-
therapy significantly improves symptoms and the quality
of life of patients with liver cancer, only modest increase
in survival rate can be achieved. Faced with palliative
care, many cancer patients use alternative medicines, in-
cluding herbal therapies. Conventional chemotherapy re-
mains ineffective in curing hepatocellular carcinoma due
to its high hepatotoxicity. Several plant-based extracts
have been shown to be effective in liver cancer therapy
and prevention [17]. Given the several health promoting
attributes to C. speciosus, the principle objective of the
study was to evaluate and establish the anticancer efficacy
of C. speciosus tuber extracts using human hepatocellular
carcinoma cell lines. Previous work demonstrated in C.
speciosus rhizome extract exhibited antioxidant and anti-
proliferative properties in human cancer cell lines [18].
Our study represents the first time to study anticancer ac-
tivity, apoptotic and inhibitory effects on cell proliferation
of diosgenin isolated from C. speciosus.
Anticancer activity
Investigation of the anticancer activity of the tested sam-
ple was carried out using three different human cancer
cell lines and assayed by a metabolic viability test (MTT).
The results indicated that the treatment of HepG2 cells
with the sample resulted in a cytotoxic effect as concluded
from the IC50 value 32.62 μg/ml, as shown in Fig. 2a,
while the treatment of HepG2 cells with paclitaxel, a
known anti-cancer drug, resulted in an IC50 value of
0.48 μg/ml. In HL-60 Cells, the sample treatment re-
sulted in moderate inhibition of the cell viability, as
shown at Fig. 2b, and resulted in an IC50 value of
22.98 μg/ml, while the treatment of HCT-116 cells with
paclitaxel resulted in an IC50 value of 0.78 μg/ml. The
treatment of MCF-7 cells with the tested sample re-
sulted in high inhibition in the cell viability, as shown
at Fig. 2c, and resulted in an IC50 value of 11.03 μg/ml,
while the treatment of MCF-7 cells with paclitaxel re-
sulted in an IC50 value of 0.61 μg/ml.
Breast cancer is the most frequent cancer among women.
Approximately 1.67 million new breast cancer cases were
reported in 2012, which accounts for 25 % of all new diag-
nosed cancer [19]. The current treatment strategies for
breast cancer patients such as surgery, chemotherapy and
radiotherapy or the combination of radiotherapy and
chemotherapy have successfully increased the five-year sur-
vival rate of the breast cancer patients. Nevertheless, the
long-term survival remains poor due to cancer relapse and
metastasis. In the present study, diosgenin exhibited strong
cytotoxic properties against caspase-3 deficient MCF-7 cells
(Fig. 2c). According to the National Cancer Institute guide-
lines, diosgenin is a great candidate to be developed as an
anticancer agent for breast cancer as the IC50 value was less
than 11.03 μg/mL towards MCF-7 cells after treatment for
72 h [20]. Diosgenin treatment on MCF-7 cell lines showed
significant decrease in growth rate compared with control.
On the other hand the percentage of non-viable cells on
cell lines increased with the increasing period of treatment.
These results were in concordance with the studies investi-
gated the cytotoxic effect of Goniothalamin towards human
breast cancer cells by Al- Qubaisi et al. [21]. Hence present
study shows the efficacy of diosgenin for the cytotoxicity
towards MCF-7 cells thus suggesting protection against
breast cancer.
Fig. 2 The cytotoxicity (% of control) of different concentrations (μg/ml) of the tested sample against (a) human HepG2, (b) human HL-60 and (c)
human MCF-7 cells after 24 h of incubation as assayed by MTT. (n = 4)
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Cell cycle analysis
In order to explain the anti-cancer property of the tested
sample in MCF-7 cells, we investigated their role in cell
cycle progression. As shown in Fig. 3, treatment of cells
with tested sample (30 % of the IC50) resulted in a predom-
inated growth arrest at the S- and G2/M-phases (P < 0.01),
where the large cell population at S-phase represents a
considerable delay in the progression in that phase, as
compared with control cells. No evident sub-G0/G1 peak
was noted after the sample.
Fluorescence analysis of apoptosis and necrosis in living
cells
Acridine orange (AO) stained both live and dead cells,
while ethidium bromide (EB) stained only cells with lost
membrane integrity. Living cells will appear green, while
early apoptotic cells are containing bright green to yel-
low dots in the nuclei due to chromatin condensation
and nuclear fragmentation. Late apoptotic cells also have
EB (orange), but unlike necrotic cells, the late apoptotic
cells exhibited condensed and fragmented nuclei. Nec-
rotic cells are in deep orange to red, but have a nuclear
morphology resembling that of living cells, with no con-
densed chromatin. The percentages of vital, apoptotic
and necrotic cells were determined and compared with
untreated cells, as demonstrated in Fig. 4. As shown in
Fig. 5, MCF-7 cells treated with the tested sample and
paclitaxel, using half IC50 concentration of each, showed
a significant (P < 0.05) increase in the total percentage of
cell death into >50 %, where there was a significant in-
crease in both of apoptotic and necrotic cell populations,
however the majority population in dead cells in the
tested sample and paclitaxel was apoptotic population.
Estimation of caspase-3 and death receptor 4
Apoptosis can be started through two distinct pathways,
the death receptor (extrinsic pathway) mitochondrial
mediated (intrinsic pathway). Both lead to activation of
the caspase cascades "executioner caspases" such as
caspase-3, −6 and −7. The active executioner caspases
bind cellular substrates, leading to the characteristic bio-
chemical and morphological changes observed in dying
cells. This is followed by chromatin condensation, nu-
clear shrinkage and DNA fragmentation. Binding of
cytoskeletal proteins leads to cell fragmentation and for-
mation of apoptotic bodies [22, 23]. As shown in Fig. 6,
the levels of DR4 and caspase-3 were significantly in-
creased (P < 0.01) in MCF-7 cells treated with the tested
sample compared to untreated cells and possessed a
similar activity of paclitaxel in DR4 induction but lower
induction in caspase-3.
Proliferation index of lymphocytes and macrophages
Investigation of the effect of the tested sample on the
proliferation of the immune cells was carried out using
two different immune cell lines and assayed by a MTT
Fig. 3 Cell cycle analysis of MCF-7 cells: DNA frequency distribution of cells cultured in control (left), Sample-treated (right), in one
representative capture
Fig. 4 Representative images for the mode of cell death in the
sample-treated MCF-7 cells (50 % of IC50), as stained by AO/EB and
captured under fluorescence microscope (x200). Vital cells (green),
early apoptotic (bright green to yellow), late apoptotic (orange) and
necrotic cells (red)
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test. The results indicated that the treatment of macro-
phages and lymphocytes with different sample concen-
trations resulted in no change in the proliferation index
compared to the control untreated cells, as shown in
Fig. 7. On the other hand the treatment of macrophages
or lymphocytes with diosgenin (250 μg/ml) resulted in
an induction in the cell proliferation up to 3.2-fold and
2.1-fold of control, respectively.
Conclusion
In conclusion, our current study is the first to identify
the remarkable anticancer activity of, apoptotic and in-
hibitory effects on cell proliferation of diosgenin isolated
from C. speciosus. Our data generate compelling evi-
dence for further evaluation of this constituent as chemo
preventive regimen for liver cancer. These studies are
valuable for identifying plant-based chemotherapeutic
drugs as currently used liver cancer drug causes many
side effects. However, animal and human studies are in-
deed required to prove the safety and efficacy of applica-
tion of diosgenin of C. speciosus as a potential chemo
preventive agent in clinical practice.
Fig. 5 The cell population percentage of vital (white segments), apoptotic (black segment) and necrotic (gray segments) cells were counted after
treatment with the tested sample and paclitaxel. Results represent the mean of three independent experiments
Fig. 6 The effect of treatment with the tested sample (black bars, 50 %
of IC50) on apoptotic cell death pathway in MCF-7 cells compared with
paclitaxel activity (gray bars). DR4 and caspase-3 levels in treated cells
were compared with control cells. The data represented as number of
folds in relation to control absorbance readings, which were 7.3, and
6.5 milliabsorbance, respectively
Fig. 7 The proliferation (% of control) of different concentrations
(μg/ml) of the tested sample in lymphoblastic leukemia 1301 cells
(grey line) and Raw murine macrophage RAW 264.7 (black line) after
72 h of incubation as assayed by MTT. (n = 4)
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